CMS vs RXRX · P/E 20, $22.42B cap vs rev $58.8M
CMS Energy Corporation (CMS) versus Recursion Pharmaceuticals Inc (RXRX) — a side-by-side from cached financials, not a winner call.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
CMS does not have a complete income-statement cache yet.
Latest reported RXRX revenue for 2024-12-31 was $58.8M. Net income was -$463.7M. Revenue was up 32.0% from 2023-12-31 to 2024-12-31. RXRX currently screens at market cap $1.75B.
CMS currently screens at market cap $22.42B and trailing P/E 20.1. RXRX currently screens at market cap $1.75B.
Not investment advice. Open the CMS and RXRX stock pages for the full models.
Not investment advice.